Testicular Non-Seminomatous Germ Cell Tumor — Clinical Trials

MONDO:00064472 active·1 recruitingLast updated: Mar 18, 2026, 6:58 PM

Testicular Non-Seminomatous Germ Cell Tumor has an emerging clinical trial program, driven by procedure and drug treatment.

Recruiting

Active Trials

Procedure2

Drug Treatment1

Biological Therapy1

Phase 1

Phase 2

NIH1Academic/Other1

United States2 trials

Guam1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 1Recruiting

Sponsor:City of Hope Medical Center

United StatesStarted: Mar 2026Est. completion: Jan 2031Updated: Jan 2026

Phase 2Active, Not Recruiting

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jan 2017Est. completion: May 2026Updated: Mar 2026

Stay informed about clinical trials for Testicular Non-Seminomatous Germ Cell Tumor.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 6:58 PM